0001209191-23-041799.txt : 20230707
0001209191-23-041799.hdr.sgml : 20230707
20230707162722
ACCESSION NUMBER: 0001209191-23-041799
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20230706
FILED AS OF DATE: 20230707
DATE AS OF CHANGE: 20230707
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: McCullough James Renwick
CENTRAL INDEX KEY: 0001974146
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-39387
FILM NUMBER: 231077069
MAIL ADDRESS:
STREET 1: C/O RENALYTIX PLC
STREET 2: FINSGATE, 5-7 CRANWOOD STREET
CITY: LONDON
STATE: X0
ZIP: EC1V 9EE
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: Renalytix plc
CENTRAL INDEX KEY: 0001811115
STANDARD INDUSTRIAL CLASSIFICATION: SERVICES-MEDICAL LABORATORIES [8071]
IRS NUMBER: 000000000
STATE OF INCORPORATION: DE
FISCAL YEAR END: 0630
BUSINESS ADDRESS:
STREET 1: FINSGATE
STREET 2: 5-7 CRANWOOD STREET
CITY: LONDON
STATE: X0
ZIP: EC1V 9EE
BUSINESS PHONE: 44 29 2071 0570
MAIL ADDRESS:
STREET 1: FINSGATE
STREET 2: 5-7 CRANWOOD STREET
CITY: LONDON
STATE: X0
ZIP: EC1V 9EE
FORMER COMPANY:
FORMER CONFORMED NAME: Renalytix AI plc
DATE OF NAME CHANGE: 20200430
4
1
doc4.xml
FORM 4 SUBMISSION
X0407
4
2023-07-06
0
0001811115
Renalytix plc
RNLX
0001974146
McCullough James Renwick
C/O RENALYTIX PLC
FINSGATE, 5-7 CRANWOOD STREET
LONDON
X0
EC1V 9EE
UNITED KINGDOM
1
1
0
0
Chief Executive Officer
0
Employee Stock Option (right to buy)
2023-07-06
4
A
0
875017
0.00
A
2033-07-05
Ordinary Shares
875017
875017
D
The exercise price is 1.025 pounds sterling. The U.S. dollar equivalent of the exercise price is $1.301 using the Bank of England rate as of July 6, 2023 (1.00 pound sterling = $1.269).
One twelfth (1/12th) of the shares subject to the option award shall vest in equal quarterly installments commencing on October 6, 2023, subject to the Reporting Person's continuous service.
/s/ Katie Kazem, Attorney-in-Fact
2023-07-07